Transcription-coupled repair of DNA-protein cross-links depends on CSA and CSB.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
Covalent DNA-protein cross-links (DPCs) are toxic DNA lesions that block replication and require repair by multiple pathways. Whether transcription blockage contributes to the toxicity of DPCs and how cells respond when RNA polymerases stall at DPCs is unknown. Here we find that DPC formation arrests transcription and induces ubiquitylation and degradation of RNA polymerase II. Using genetic screens and a method for the genome-wide mapping of DNA-protein adducts, DPC sequencing, we discover that Cockayne syndrome (CS) proteins CSB and CSA provide resistance to DPC-inducing agents by promoting DPC repair in actively transcribed genes. Consequently, CSB- or CSA-deficient cells fail to efficiently restart transcription after induction of DPCs. In contrast, nucleotide excision repair factors that act downstream of CSB and CSA at ultraviolet light-induced DNA lesions are dispensable. Our study describes a transcription-coupled DPC repair pathway and suggests that defects in this pathway may contribute to the unique neurological features of CS.
Description
Funder: Cancer Research UK (CRUK); doi: https://doi.org/10.13039/501100000289; Grant(s): CRUK Discovery Award DRCPGM\100005, CRUK RadNet grant C17918/A28870, CRUK Discovery Award DRCPGM\100005, Discovery Award DRCPGM\100005, A:29580, C9681/A29214, C9545/A19836
Funder: China Scholarship Council (CSC); doi: https://doi.org/10.13039/501100004543
Journal Title
Conference Name
Journal ISSN
1476-4679
Volume Title
Publisher
Publisher DOI
Rights and licensing
Sponsorship
European Commission Horizon 2020 (H2020) ERC (855741)
Wellcome Trust (209441/Z/17/Z)
Cancer Research UK (C17918/A28870)
Wellcome Trust (203144/A/16/Z)
Cancer Research UK (19836)
Cancer Research UK (C9681/A29214)

